Dr. Abbruzzese is Chief of the Division of Medical Oncology and Associate Director for Clinical Research for the Duke Cancer Institute and Chair of the National Cancer Institute Clinical Trials and Translational Research Advisory Committee. Dr. Abbruzzese joined Duke in November 2013 from M.D. Anderson Cancer Center, where he was chairman of the Department of Gastrointestinal Medical Oncology and Digestive Diseases and is a leading expert in the clinical study and treatment of pancreatic cancer.

Dr. Parmigiani is Professor of Biostatistics at Harvard University and Chair of the Department of Biostatistics and Computational Biology at the Dana-Farber Cancer Institute. Dr. Parmigiani is an expert in Bayesian methods and one of the foremost biostatistical methodologists and practitioners in cancer clinical trials and cancer genomics.

Dr. Begg is Attending Biostatistician and Chair of the Department of Epidemiology and Biostatistics at the Memorial Sloan-Kettering Cancer Center. Dr. Begg is a leading expert in biostatistical methods, clinical trials, and applications in cancer research.